Nautilus Biotechnology, Inc. (NAUT)
2.75
+0.01
(+0.36%)
USD |
NASDAQ |
Mar 19, 13:33
Nautilus Biotechnology EPS Diluted (Quarterly) : -0.109 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Nephros, Inc. | 0.0055 |
| Pyxis Oncology, Inc. | -0.3517 |
| ProKidney Corp. | -0.122 |
| Neumora Therapeutics, Inc. | -0.3507 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -13.78M |
| Total Expenses (Quarterly) | 13.78M |
| Enterprise Value | 273.40M |
| Earnings Yield | -16.99% |
| Normalized Earnings Yield | -16.99 |